Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers April 19, 2019
Pharmacy Choice - Pharmaceutical News - Metastatic Colorectal Cancer - Pipeline Review, H1 2015 - April 19, 2019

Pharmacy News Article

 9/10/15 - Metastatic Colorectal Cancer - Pipeline Review, H1 2015

Dublin - Research and Markets ( has announced the addition of the "Metastatic Colorectal Cancer - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Metastatic Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Colorectal Cancer and special features on late-stage and discontinued projects.

the report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from the proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by the team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned

Partial list of the 70 companies featured in this comprehensive report:

- AbbVie

- Actinium Pharmaceuticals

- Bavarian Nordic

- Bayer

- Celgene

- Celltrion

- DanDrit Biotech

- Eisai

- Eli Lilly and Company

- F. Hoffmann-La Roche

- Genentech

- Genor BioPharma

- Hospira

- Hutchison MediPharma

- Ignyta

- Immodulon Therapeutics

- Kadmon Corporation

- Karyopharm Therapeutics

- Mabion

- MacroGenics

- Nektar Therapeutics

- Nippon Kayaku

- Oncobiologics

- Oncolytics Biotech

- Panacea Biotec

- Pfizer

- Regeneron Pharmaceuticals

- Simcere Pharmaceutical

- Symphogen

- TetraLogic Pharmaceuticals

For more information visit


Research and Markets,

Laura Wood,

Senior Manager.

Fax from USA: 646-607-1907

Fax from rest of the world: +353-1-481-1716

Sector: Oncology (



Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Apr 22: Can Pharmacy Malpractice Be a Crime?
Apr 23: Management of Bipolar Disorder
Apr 24: Identifying, Targeting and Managing Chronic Renal Failure
Apr 25: COPD Update for Pharmacy Professionals
Apr 28: Pharmacy & the Opioid Crisis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement